FRANK N OPPONG TAKYI

Allopathic & Osteopathic Physicians|Internal Medicine PHOENIX, AZ NPI 1497770465

General Payments — all program years on this page

$1,486.34

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $677.50 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $677.5016

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $260.4910
2019 $175.098
2020 $61.984
2021 $70.474
2022 $76.085
2023 $164.7310
2024 $677.5016

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096580293 Novo Nordisk Inc $15.23 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096715767 Novo Nordisk Inc $90.94 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097416826 Novo Nordisk Inc $28.11 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097462164 Novo Nordisk Inc $16.25 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104652095 AstraZeneca Pharmaceuticals LP $53.26 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104687762 AstraZeneca Pharmaceuticals LP $14.48 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104754052 AstraZeneca Pharmaceuticals LP $115.05 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105507368 AstraZeneca Pharmaceuticals LP $121.82 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105681847 AstraZeneca Pharmaceuticals LP $23.91 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105869289 AstraZeneca Pharmaceuticals LP $84.53 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114817214 Exact Sciences Corporation $15.57 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116623369 GlaxoSmithKline, LLC. $22.14 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118034027 Boehringer Ingelheim Pharmaceuticals, Inc. $15.46 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118034029 Boehringer Ingelheim Pharmaceuticals, Inc. $18.19 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126992750 Vertical Pharmaceuticals, LLC $21.01 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131309428 PFIZER INC. $21.55 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.